QBM

QBM Cell Science is a biotechnology company specializing in the preparation and distribution of high-quality, cryopreserved primary neurons and other cells from the central nervous system. The company provides researchers with standardized, ready-to-use primary cells to improve the reproducibility and efficiency of neuroscience research. Their product portfolio includes cells from various brain regions, such as the hippocampus, cortex, and striatum, as well as specialized media and reagents. By offering validated cell products, QBM Cell Science supports drug discovery and basic research in neurodegenerative diseases like Alzheimer's and Parkinson's. The company was acquired by Neuromics in 2021, integrating its specialized cell culture expertise into a broader life sciences reagent platform.